Cataracts associated with allopurinol therapy

Area of Science:

• Ophthalmology
• Pharmacology
• Toxicology

Background:

• Allopurinol is a widely prescribed antihyperuricemic agent.
• Drug-induced ocular side effects are a significant concern in patient safety.
• Lens changes can lead to vision impairment.

Purpose of the Study:

• To investigate suspected cases of allopurinol-induced lens changes.
• To characterize the nature of cataracts associated with allopurinol use.
• To assess the potential cataractogenic effects of allopurinol.

Main Methods:

• Review of 30 case reports submitted to the National Registry of Drug-Induced Ocular Side Effects.
• Clinical description of lens changes observed in suspected cases.
• Histologic examination of cataractous lens material.

Main Results:

• Thirty cases of suspected allopurinol-induced lens changes were documented.
• Cataracts presented initially as anterior and posterior lens capsule changes with subcapsular vacuoles.
• Progression involved wedge-shaped cortical haze and dense posterior subcapsular cataracts; histology showed no unique features.

Conclusions:

• While a definitive cause-and-effect relationship is not proven, these findings raise suspicion that allopurinol may be cataractogenic in certain patients.
• Further case reports and lens material are encouraged for continued investigation.
• Ophthalmologists and healthcare providers should be aware of this potential ocular side effect.